See more : Premier Development & Investment, Inc. (PDIV) Income Statement Analysis – Financial Results
Complete financial analysis of Pharma Equity Group A/S (PEG.CO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharma Equity Group A/S, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Nippon Kodoshi Corporation (3891.T) Income Statement Analysis – Financial Results
- Dynamic Industries Limited (DYNAMIND.BO) Income Statement Analysis – Financial Results
- Man Group Limited (EMG.L) Income Statement Analysis – Financial Results
- Arcadia Minerals Limited (AM7.AX) Income Statement Analysis – Financial Results
- Apoorva Leasing Finance and Investment Company Limited (APOORVA.BO) Income Statement Analysis – Financial Results
Pharma Equity Group A/S (PEG.CO)
About Pharma Equity Group A/S
Pharma Equity Group A/S invests in companies with a primary focus on life sciences. It focuses on early investment in life science companies that develop technologies and therapies that enhances human health and quality of life. The company is based in Hørsholm, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.05M | 620.00K | 0.00 | 0.00 | 13.25M | 15.49M | 517.00K | 0.00 | 0.00 |
| Cost of Revenue | 480.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.53M | 7.10M | 147.00K | 0.00 | 0.00 |
| Gross Profit | -480.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.05M | 620.00K | 0.00 | 0.00 | 6.72M | 8.38M | 370.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 50.74% | 54.13% | 71.57% | 0.00% | 0.00% |
| Research & Development | 9.08M | 5.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.81K | 1.98M | 1.44M | 2.14M | 1.67M | 1.67M | 1.98M | 1.76M | 3.09M | 2.00M | 5.24M | 6.78M | 6.89M | 5.52M | 967.00K | 0.00 |
| Selling & Marketing | 15.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 15.73M | 1.98M | 1.44M | 2.14M | 1.67M | 1.67M | 1.98M | 1.76M | 3.09M | 2.00M | 5.24M | 6.78M | 6.89M | 5.52M | 967.00K | 0.00 |
| Other Expenses | 0.00 | 3.03M | 4.91M | -6.62M | -7.39M | 50.00K | -1.98M | -1.76M | -3.09M | 0.00 | -118.81M | -6.52M | 3.96M | 8.52M | 0.00 | -92.67M |
| Operating Expenses | 24.81M | 2.78M | -56.00K | 12.14M | 1.67M | 1.67M | 1.98M | 1.76M | 3.09M | 2.00M | 5.24M | 6.78M | 6.89M | 5.52M | 967.00K | -92.67M |
| Cost & Expenses | 25.29M | 2.78M | -56.00K | 12.14M | 1.67M | 1.67M | 1.98M | 1.76M | 3.09M | 2.00M | 5.24M | 13.31M | 13.99M | 5.67M | 967.00K | -92.67M |
| Interest Income | 14.00K | 1.45M | 1.15M | 0.00 | 0.00 | 3.61M | 4.39M | 1.05M | 312.00K | 132.00K | 1.38M | 1.82M | 24.00K | 13.00K | 43.00K | 0.00 |
| Interest Expense | 1.56M | 996.00K | 665.00K | 272.00K | 30.00K | 125.00K | 505.00K | 1.37M | 1.12M | 4.09M | 20.49M | 24.82M | 27.87M | 5.25M | 61.00K | 0.00 |
| Depreciation & Amortization | 480.00K | 539.00 | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 462.00K | 105.00K | 7.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -24.80M | 4.48M | 6.06M | -32.60M | -14.39M | -7.59M | 177.00K | -2.02M | -2.63M | -5.99M | -135.32M | -4.75M | 1.49M | 3.38M | -924.00K | -92.67M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -61.10% | -423.71% | 0.00% | 0.00% | -35.84% | 9.63% | 654.55% | 0.00% | 0.00% |
| Operating Income | -25.29M | -4.28M | -1.44M | -2.14M | -1.67M | -1.67M | -1.98M | -1.76M | -3.09M | -2.00M | -5.24M | -4.75M | 1.49M | 3.38M | -924.00K | -92.67M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -166.60% | -498.23% | 0.00% | 0.00% | -35.84% | 9.63% | 654.55% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.55M | 7.75M | 6.84M | -15.26M | -12.75M | -6.04M | 2.16M | -259.00K | -653.00K | -3.99M | -11.84M | -24.82M | -23.88M | 3.28M | -5.00K | 0.00 |
| Income Before Tax | -26.84M | 3.48M | 5.39M | -32.88M | -14.42M | -7.71M | 177.00K | -2.02M | -3.74M | -5.99M | -17.08M | -29.57M | -22.39M | -1.87M | -985.00K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -191.18% | -603.55% | 0.00% | 0.00% | -223.14% | -144.58% | -361.51% | 0.00% | 0.00% |
| Income Tax Expense | -2.23M | -7.30M | -6.35M | 15.48M | 5.55M | -5.34M | -4.39M | -2.03M | -1.59M | -62.00K | 6.60M | 13.71M | -5.41M | -454.00K | -246.00K | 92.67M |
| Net Income | -24.61M | 3.48M | 5.39M | -32.88M | -14.42M | -7.71M | 177.00K | -1.04M | -2.77M | -5.93M | -141.83M | -43.28M | -16.98M | -1.42M | -12.04M | -92.67M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -98.20% | -447.26% | 0.00% | 0.00% | -326.58% | -109.63% | -273.69% | 0.00% | 0.00% |
| EPS | -0.02 | 0.09 | 0.10 | -1.03 | -0.07 | -0.32 | 0.01 | -0.06 | -0.13 | -3.00 | -93.59 | -28.56 | -12.25 | -1.60 | -14.16 | -109.99 |
| EPS Diluted | -0.02 | 0.08 | 0.10 | -1.03 | -0.07 | -0.32 | 0.01 | -0.06 | -0.13 | -3.00 | -93.57 | -24.56 | -9.86 | -1.60 | -14.16 | -109.99 |
| Weighted Avg Shares Out | 1.08B | 37.29M | 55.57M | 31.82M | 203.79M | 23.82M | 22.23M | 18.69M | 21.74M | 1.98M | 1.52M | 1.52M | 1.39M | 883.89K | 849.79K | 842.53K |
| Weighted Avg Shares Out (Dil) | 1.08B | 44.36M | 55.57M | 31.82M | 203.79M | 23.82M | 22.23M | 18.69M | 21.74M | 1.98M | 1.52M | 1.76M | 1.72M | 883.89K | 849.79K | 842.53K |
No news found for: PEG.CO
Source: https://incomestatements.info
Category: Stock Reports